Research Article
Prognostic Value of 18F-Fluorocholine PET Parameters in Metastatic Castrate-Resistant Prostate Cancer Patients Treated with Docetaxel
Table 3
Cox regression analysis for progression-free survival and overall survival according to PET parameters.
| | Cox regression analysis | | Parameters | PFS | OS | | HR | 95% CI | | HR | 95% CI | |
| | SPVC-SUV 18F-FCH PET/CT | 1.025 | 0.99–1.05 | 0.12 | 1.07 | 0.96–1.05 | 0.76 | | SSUVmax18F-FCH PET/CT | 1.022 | 0.99–1.05 | 0.118 | 1.03 | 0.97–1.03 | 0.85 | | SMATV 18F-FCH PET/CT | 1.069 | 1.06–1.09 | 0.005 | 1.01 | 0.99–1.02 | 0.09 | | STLA 18F-FCH PET/CT | 1.04 | 1.02–1.08 | 0.012 | 1.0 | 0.99–1.01 | 0.38 |
|
|
